Results

• All
• Video
• Audio
• Images

• Most recent

1–3 of 3 results for Daniel Su

• 

  ZETA-1 Phase 2 Trial Safety and Tolerability Results for APX3330 a New Oral Ref-1 Inhibitor for the Treatment of Diabetic Retinopathy

  Daniel Su, MD

  Annual Meeting Talks

  2023

• 

  Outcomes in Proliferative Diabetic Retinopathy Patients Lost to Follow-up After Panretinal Photocoagulation Versus Antivascular Endothelial Growth Factor

  Daniel Su, MD

  Annual Meeting Talks

  2018

• 

  Outcomes in Proliferative Diabetic Retinopathy Patients Lost to Follow-up After Panretinal Photocoagulation Versus Antivascular

  Daniel Su, MD

  Updates from the Field

  2018